
    
      Primary objective: to compare the MicroPort Medical (Group) Co., Ltd Firehawkâ„¢cobalt chromium
      coronary stent ( rapamycin target eluting ) system with abluminal grooves containing a
      biodegradable polymer with the Abbott XIENCE family EES (Everolimus-Eluting stent) system
      with respect to cardiac death, myocardial infarction (not clearly attributable to a
      non-target vessel), Target Lesion Revascularization at 1 year in a "real world" patient
      population.
    
  